STOCK TITAN

American Healthcare REIT (AHR) prices additional 2.1M shares via forward sale

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

American Healthcare REIT, Inc. reports that the underwriter in its recent equity offering has fully exercised its option to purchase an additional 2,100,000 shares of common stock. These shares were sold on May 28, 2026 through a forward sale structure with an affiliate of BofA Securities, Inc.

The company intends to physically settle the additional forward sale agreement by delivering 2,100,000 shares to the forward purchaser by May 20, 2028 in exchange for cash based on the public offering price, less the underwriting discount and subject to adjustments. It plans to contribute the net proceeds to its operating partnership for general corporate purposes, including potential future investments.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Primary offering size 14,000,000 shares Public offering of common stock closed May 22, 2026
Underwriter option shares 2,100,000 shares Additional shares tied to underwriter option and forward sale
Settlement deadline May 20, 2028 Latest date for physical settlement of additional forward sale
Par value $0.01 per share Common stock par value
Form type Form 8-K Item 8.01 Other events disclosure about underwriter option and forward sale
forward sale agreement financial
"we entered into an additional forward sale agreement, or the Additional Forward Sale Agreement, with an affiliate of the Underwriter"
A forward sale agreement is a contract where a holder of securities or assets agrees to sell them at a fixed price on a specific future date, like a farmer locking in a price for next season’s crop. For investors this matters because it creates predictable future cash or supply and reduces price uncertainty, but it can limit upside if prices rise and introduces risk if the other party fails to deliver or payment affects shareholder value through dilution or financing choices.
shelf registration statement regulatory
"pursuant to our effective shelf registration statement on Form S-3 (File No. 333-281488)"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
underwriter financial
"BofA Securities, Inc., as underwriter, or in such capacity, the Underwriter, was granted an option"
An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.
prospectus supplement regulatory
"The additional shares were offered and sold under a prospectus supplement and related prospectus"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Operating Partnership financial
"to American Healthcare REIT Holdings, LP, or our Operating Partnership, in exchange for units"
An operating partnership is a separate legal entity set up to own and run a company’s core assets and day-to-day businesses, while investors hold interests indirectly through the parent company. Think of it like a dedicated garage that actually stores and services the cars while the owner keeps the dealership; it matters to investors because it affects how income, taxes, liability and voting rights are allocated and therefore can influence distributions and risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did American Healthcare REIT (AHR) announce in this Form 8-K?

American Healthcare REIT announced that the underwriter fully exercised its option for 2,100,000 additional common shares tied to a recent offering. These shares are being sold through an additional forward sale agreement and will generate cash for general corporate purposes upon settlement.

How many additional American Healthcare REIT (AHR) shares are covered by the new forward sale agreement?

The additional forward sale agreement covers 2,100,000 shares of American Healthcare REIT common stock. These shares relate to the full exercise of the underwriter’s 30-day option connected to the previously closed 14,000,000-share public offering completed on May 22, 2026.

When must American Healthcare REIT settle the additional forward sale agreement?

American Healthcare REIT intends to physically settle the additional forward sale agreement by delivering shares no later than May 20, 2028. Settlement can occur on one or more dates the company specifies, with the cash price per share based on the offering price, less underwriting discounts and adjustments.

How will American Healthcare REIT (AHR) use the cash proceeds from the additional forward sale agreement?

The company plans to contribute the net cash proceeds from settling the additional forward sale agreement to American Healthcare REIT Holdings, LP. In return, it will receive operating partnership units, and the partnership intends to use funds for general corporate purposes, including potential future investments.

What pricing terms apply to the 2,100,000 AHR shares under the additional forward sale agreement?

Cash proceeds per share will equal the public offering price less the underwriting discount, subject to adjustments provided in the additional forward sale agreement. This structure links the eventual settlement price to the original offering terms rather than prevailing market prices at settlement.

Under which registration statement were the additional American Healthcare REIT shares offered?

The additional 2,100,000 American Healthcare REIT common shares were offered and sold under a prospectus supplement and related prospectus. These documents were filed pursuant to the company’s effective shelf registration statement on Form S-3, File No. 333-281488.
0001632970false00016329702026-05-262026-05-26

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 26, 2026

 

 

American Healthcare REIT, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Maryland

001-41951

47-2887436

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

18191 Von Karman Avenue, Suite 300

 

Irvine, California

 

92612

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 949 270-9200

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

AHR

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 8.01 Other Events.

 

As previously announced, on May 22, 2026, we closed the public offering of 14,000,000 shares, or the Offering, of our common stock, $0.01 par value per share, or Common Stock. In connection with the Offering, BofA Securities, Inc., as underwriter, or in such capacity, the Underwriter, was granted an option for 30 days to purchase up to 2,100,000 additional shares of Common Stock.

 

On May 26, 2026, in connection with the exercise in full of the Underwriter’s option to purchase additional shares, or the option exercise, we entered into an additional forward sale agreement, or the Additional Forward Sale Agreement, with an affiliate of the Underwriter, as forward purchaser, or in such capacity, the Forward Purchaser.

 

In connection with the option exercise, BoA Securities, Inc., as forward seller, or in such capacity, the Forward Seller, borrowed and sold an aggregate of 2,100,000 shares of Common Stock on May 28, 2026 to hedge the Forward Purchaser’s obligations under the Additional Forward Sale Agreement. We intend (subject to our right to elect cash or net share settlement subject to certain conditions) to deliver, upon physical settlement of the Additional Forward Sale Agreement on one or more dates specified by us occurring no later than May 20, 2028 (or if such date is not a trading day, the next following trading day), an aggregate of 2,100,000 shares of Common Stock to the Forward Purchaser in exchange for cash proceeds per share equal to the applicable forward sale price, which will be the public offering price less the underwriting discount and subject to certain adjustments as provided in the Additional Forward Sale Agreement. We intend to contribute the net proceeds from the settlement of the Additional Forward Sale Agreement to American Healthcare REIT Holdings, LP, or our Operating Partnership, in exchange for units of limited partnership interest in the Operating Partnership, and the Operating Partnership intends to use such net proceeds for general corporate purposes, including potential future investments.

The additional shares were offered and sold under a prospectus supplement and related prospectus filed with the Securities and Exchange Commission pursuant to our effective shelf registration statement on Form S-3 (File No. 333-281488).

A copy of the Additional Forward Sale Agreement is attached hereto as Exhibit 1.1 and incorporated herein by reference. The summary of the Additional Forward Sale Agreement set forth herein is qualified in its entirety by reference to this exhibit.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

1.1

 

Forward Confirmation, dated May 26, 2026, between the Company and BofA Securities, Inc. (or its affiliate)

5.1

 

Opinion of Venable LLP as to the legality of the Common Stock (included as Exhibit 5.1 to our Current Report on Form 8-K (File No. 001-41951) filed May 22, 2026 and incorporated herein by reference)

23.1

 

Consent of Venable LLP (included as Exhibit 5.1 to our Current Report on Form 8-K (File No. 001-41951) filed May 22, 2026 and incorporated herein by reference)

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

American Healthcare REIT, Inc.

 

 

 

 

Date:

May 28, 2026

By:

/s/ Jeffrey T. Hanson

 

 

 

Name: Jeffrey T. Hanson
Title: Interim Chief Executive Officer and President

 


Filing Exhibits & Attachments

2 documents